Folate fortification and supplementation do not provide vascular health benefits in type 1 diabetes

Alexia Sophie Peña1, Oana Maftei, Kate Dowling

  • 1Department of Pediatrics, University of Adelaide, Adelaide, South Australia, Australia. alexiasophie@yahoo.com

The Journal of Pediatrics
|February 5, 2013
PubMed

Insights

Mandatory folate fortification improved folate status and vascular function in children with type 1 diabetes. Additional folic acid supplementation did not further enhance endothelial function in these children.

Area of Science:

  • Pediatric Endocrinology
  • Cardiovascular Health
  • Nutritional Science

Background:

  • Type 1 diabetes is associated with endothelial dysfunction.
  • Mandatory folate fortification in Australia may impact folate status and vascular health in children.
  • Previous studies suggested a potential benefit of folic acid on endothelial function.

Purpose of the Study:

  • To determine the lowest effective dose of folic acid for improving endothelial function in children with type 1 diabetes.
  • To assess the dose-response relationship of folic acid supplementation on endothelial function.
  • To compare endothelial function in children with type 1 diabetes before and after mandatory folate fortification.

Main Methods:

  • Randomized, double-blind, crossover, placebo-controlled trial.
  • 20 children with type 1 diabetes received folic acid (0.5, 2, 5 mg) or placebo.
  • Endothelial function assessed by flow-mediated dilatation (FMD) 2 hours post-intervention.

Main Results:

  • Folic acid supplementation increased serum and red blood cell folate levels.
  • No significant improvement in flow-mediated dilatation (FMD) was observed with any folic acid dose.
  • Children post-fortification had significantly higher baseline folate levels and improved vascular function compared to pre-fortification.

Conclusions:

  • Mandatory folate fortification has improved folate status and endothelial function in children with type 1 diabetes.
  • Additional folic acid supplementation does not provide further endothelial benefits in this population.
  • The established folate status likely saturates the beneficial effects of folic acid on vascular function.
Abstract

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...